Mosaic ImmunoEngineering (CPMV) Interest & Investment Income (2010 - 2025)
Mosaic ImmunoEngineering (CPMV) posted quarterly Interest & Investment Income of $1.0 for Q4 2025, little changed year-over-year from $1.0 in Q4 2024, and little changed quarter-over-quarter from $1.0 in Q3 2025.
Mosaic ImmunoEngineering (CPMV) Interest & Investment Income (2010 - 2025) Analysis & Trends
Mosaic ImmunoEngineering's Interest & Investment Income history runs 16 years deep, the most recent figure standing at $1.0 for Q4 2025.
- In Q4 2025, Interest & Investment Income changed 0.0% year-over-year to $1.0; the TTM figure through Mar 2026 stood at $3.0 (down 40.0% YoY), while the FY2025 annual figure was $6.0, up 20.0% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $1.0, roughly flat from $1.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $3378.0 in Q2 2023, with the low at $1.0 in Q2 2024.
- The 5-year median for Interest & Investment Income is $7.0 (2022), against an average of $183.58.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income surged 48157.14% in 2023, then sank 99.97% in 2024.
- Mosaic ImmunoEngineering's Interest & Investment Income stood at $8.0 in 2021, then changed by 0.0% to $8.0 in 2022, then retreated by 25.0% to $6.0 in 2023, then plunged by 83.33% to $1.0 in 2024, then changed by 0.0% to $1.0 in 2025.
- Business Quant data shows CPMV's Interest & Investment Income at $1.0 in Q4 2025, $1.0 in Q3 2025, and $1.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 |
| Sep 30, 2025 | 1.00 |
| Jun 30, 2025 | 1.00 |
| Mar 31, 2025 | 3.00 |
| Dec 31, 2024 | 1.00 |
| Jun 30, 2024 | 1.00 |
| Mar 31, 2024 | 3.00 |
| Dec 31, 2023 | 6.00 |
| Sep 30, 2023 | 16.00 |
| Jun 30, 2023 | 3,378.00 |
| Mar 31, 2023 | 8.00 |
| Dec 31, 2022 | 8.00 |
| Sep 30, 2022 | 11.00 |
| Jun 30, 2022 | 7.00 |
| Mar 31, 2022 | 7.00 |
| Dec 31, 2021 | 8.00 |
| Sep 30, 2021 | 12.00 |
| Jun 30, 2021 | 11.00 |
| Mar 31, 2021 | 5.00 |
| Nov 30, 2020 | 59.00 |